QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer's diseaseGlobeNewsWire • 09/04/24
QIAGEN N.V. announces conversion price of new net share settled convertible bondsGlobeNewsWire • 09/03/24
QIAGEN N.V. announces successful placement of new net share settled convertible bondsGlobeNewsWire • 09/03/24
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic DiseasesZacks Investment Research • 08/30/24
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseasesGlobeNewsWire • 08/28/24
Unlocking Qiagen (QGEN) International Revenues: Trends, Surprises, and ProspectsZacks Investment Research • 08/05/24
Compared to Estimates, Qiagen (QGEN) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/01/24
Qiagen (QGEN) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 07/24/24
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in childrenGlobeNewsWire • 06/27/24